Abstract
The synthesis of 1,2-substituted benzimidazoles is reported. These novel derivatives share chemical similarities with 1-aryl-1H,3H-thiazolo[3,4-a]benzimidazoles, a class of HIV-1 NNRTIs studied widely. All compounds prepared were tested in MT-4 cells to explore their potential anti-HIV activity and were found to be less potent than 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazole (TBZ).
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-HIV Agents / chemical synthesis*
-
Anti-HIV Agents / pharmacology*
-
Benzimidazoles / chemistry*
-
Benzimidazoles / pharmacology*
-
Cell Line, Transformed
-
HIV-1 / drug effects
-
HIV-2 / drug effects
-
Humans
-
Lethal Dose 50
-
Models, Molecular
-
Reverse Transcriptase Inhibitors / chemical synthesis
-
Reverse Transcriptase Inhibitors / pharmacology
-
Structure-Activity Relationship
-
Virus Replication / drug effects
Substances
-
Anti-HIV Agents
-
Benzimidazoles
-
Reverse Transcriptase Inhibitors